Talin1 phosphorylation activates β1 integrins: A novel mechanism to promote prostate cancer bone metastasis

Oncogene

Volumn 34, Issue 14, 2014, Pages 1811-1821

  Jin, J K ^a,b   Tien, P C ^a   Cheng, C J ^c   Song, J H ^a   Huang, C ^d   Lin, S H ^a,b   Gallick, G E ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CDCA5 PROTEIN, HUMAN; CDK5 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 5; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TALIN; TLN1 PROTEIN, HUMAN; TLN2 PROTEIN, HUMAN;

ANIMAL; ANOIKIS; BIOSYNTHESIS; BONE TUMOR; CELL ADHESION; CELL MOTION; ENZYME ACTIVATION; FOCAL ADHESION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; PROSTATE; PROSTATE TUMOR; RNA INTERFERENCE; SECONDARY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANOIKIS; ANTIGENS, CD29; BONE NEOPLASMS; CELL ADHESION; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE 5; ENZYME ACTIVATION; FOCAL ADHESIONS; HUMANS; LYMPHATIC METASTASIS; MALE; MICE; PHOSPHORYLATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN BINDING; RNA INTERFERENCE; RNA, SMALL INTERFERING; TALIN;

EID: 84899607537     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.116     Document Type: Article

References (45)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.
2. American Cancer Society. Cancer Facts, Figures, American Cancer Society: Atlanta, GA, USA, 2013.
3. Jin JK, Dayyani F, Gallick GE. Steps in prostate cancer progression that lead to bone metastasis. Int J Cancer 2011; 128: 2545-2561.
4. Sakamoto S, McCann RO, Dhir R, Kyprianou N. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 2010; 70: 1885-1895.
5. Lai MT, Hua CH, Tsai MH, Wan L, Lin YJ, Chen CM et al. Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis. J Pathol 2011; 224: 367-376.
6. Tang H, Yao L, Tao X, Yu Y, Chen M, Zhang R et al. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. Int J Mol Med 2013; 32: 381-388.
7. Monkley SJ, Pritchard CA, Critchley DR. Analysis of the mammalian talin2 gene TLN2. Biochem Biophys Res Commun 2001; 286: 880-885.
8. Debrand E, El Jai Y, Spence L, Bate N, Praekelt U, Pritchard CA et al. Talin 2 is a large and complex gene encoding multiple transcripts and protein isoforms. FEBS J 2009; 276: 1610-1628.
9. Manso AM, Li R, Monkley SJ, Cruz NM, Ong S, Lao DH et al. Talin1 has unique expression versus talin2 in the heart and modifies the hypertrophic response to pressure overload. J Biol Chem 2013; 288: 4252-4264.
10. Desiniotis A, Kyprianou N. Significance of talin in cancer progression and metastasis. Int Rev Cell Mol Biol 2011; 289: 117-147.
11. Goult BT, Xu XP, Gingras AR, Swift M, Patel B, Bate N et al. Structural studies on full-length talin1 reveal a compact auto-inhibited dimer: implications for talin activation. J Struct Biol 2013; 184: 21-32.
12. Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol 2013; 14: 503-517.
13. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999; 274: 28071-28074.
14. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103-106.
15. Critchley DR, Gingras AR. Talin at a glance. J Cell Sci 2008; 121: 1345-1347.
16. Ratnikov B, Ptak C, Han J, Shabanowitz J, Hunt DF, Ginsberg MH. Talin phosphorylation sites mapped by mass spectrometry. J Cell Sci 2005; 118: 4921-4923.
17. Huang C, Rajfur Z, Yousefi N, Chen Z, Jacobson K, Ginsberg MH. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol 2009; 11: 624-630.
18. Lee YC, Jin JK, Cheng CJ, Huang CF, Song JH, Huang M et al. Targeting constitutively activated beta1 integrins inhibits prostate cancer metastasis. Mol Cancer Res 2013; 11: 405-417.
19. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994; 371: 419-423.
20. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T et al. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371: 423-426.
21. Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW et al. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res 2006; 66: 7509-7515.
22. Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010; 18: 181-187.
23. Ye F, Kim C, Ginsberg MH. Molecular mechanism of inside-out integrin regulation. J Thromb Haemost 2011; 9: 20-25.
24. Martel V, Racaud-Sultan C, Dupe S, Marie C, Paulhe F, Galmiche A et al. Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J Biol Chem 2001; 276: 21217-21227.
25. Song X, Yang J, Hirbawi J, Ye S, Perera HD, Goksoy E et al. A novel membranedependent on/off switch mechanism of talin FERM domain at sites of cell adhesion. Cell Res 2012; 22: 1533-1545.
26. Yan B, Calderwood DA, Yaspan B, Ginsberg MH. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J Biol Chem 2001; 276: 28164-28170.
27. Ye F, Petrich BG, Anekal P, Lefort CT, Kasirer-Friede A, Shattil SJ et al. The mechanism of kindlin-mediated activation of integrin alphaIIbbeta3. Curr Biol 2013; 23: 2288-2295.
28. Das M, Ithychanda S, Qin J, Plow EF. Mechanisms of talin-dependent integrin signaling and crosstalk. Biochim Biophys Acta 2014; 1838: 579-588.
29. Barthel SR, Hays D, Yazawa EM, Opperman MJ, Walley KC, Nimrichter L et al. Definition of molecular determinants of prostate cancer cell bone extravasation. Cancer Res 2013; 73: 942-952.
30. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC et al. Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 2001; 12: 99-107.
31. Stachurska A, Elbanowski J, Kowalczynska HM. Role of alpha5beta1 and alphavbeta3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions. Cell Biol Int 2012; 36: 883-892.
32. Van der VeD Verdaasdonk MA, Rademakers LH, De Weger RA, Van den TwJ, Joling P. Fibronectin distribution in human bone marrow stroma: matrix assembly and tumor cell adhesion via alpha5beta1 integrin. Exp Cell Res 1997; 230: 111-120.
33. Sottnik JL, Daignault-Newton S, Zhang X, Morrissey C, Hussain MH, Keller ET et al. Integrin alpha2beta1 (alpha2beta1) promotes prostate cancer skeletal metastasis. Clin Exp Metastasis 2013; 30: 569-578.
34. Hall CL, Dai J, van Golen KL, Keller ET, Long MW. Type I collagen receptor (alpha2beta1) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Res 2006; 66: 8648-8654.
35. Lang SH, Clarke NW, George NJ, Testa NG. Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin. Clin Exp Metastasis 1997; 15: 218-227.
36. Lin TH, Liu HH, Tsai TH, Chen CC, Hsieh TF, Lee SS et al. CCL2 increases alphavbeta3 integrin expression and subsequently promotes prostate cancer migration. Biochim Biophys Acta 2013; 1830: 4917-4927.
37. Trerotola M, Jernigan DL, Liu Q, Siddiqui J, Fatatis A, Languino LR. Trop-2 promotes prostate cancer metastasis by modulating beta1 integrin functions. Cancer Res 2013; 73: 3155-3167.
38. Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 1999; 59: 1655-1664.
39. Sayeed A, Fedele C, Trerotola M, Ganguly KK, Languino LR. IGF-IR promotes prostate cancer growth by stabilizing alpha5beta1 integrin protein levels. PLoS ONE 2013; 8: e76513.
40. Cress AE, Rabinovitz I, Zhu W, Nagle RB. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 1995; 14: 219-228.
41. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996; 2: 1627-1636.
42. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994; 54: 2577-2581.
43. Chang SK, Noss EH, Chen M, Gu Z, Townsend K, Grenha R et al. Cadherin-11 regulates fibroblast inflammation. Proc Natl Acad Sci USA 2011; 108: 8402-8407.
44. Varkaris A, Gaur S, Parikh NU, Song JH, Dayyani F, Jin JK et al. Ligand-independent activation of MET through IGF-1/IGF-1R signaling. Int J Cancer 2013; 133: 1536-1546.
45. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009; 4: e6529.